| [1] |
HOLDEN CA, SPITTLE MF, JONES EW. Angiosarcoma of the face and scalp, prognosis and treatment[J]. Cancer, 1987, 59(5): 1046-1057. DOI: 10.1002/1097-0142(19870301)59:5<1046::aid-cncr2820590533>3.0.co;2-6.
|
| [2] |
LOCKER GY, DOROSHOW JH, ZWELLING LA, et al. The clinical features of hepatic angiosarcoma: A report of four cases and a review of the English literature[J]. Medicine (Baltimore), 1979, 58(1): 48-64. DOI: 10.1097/00005792-197901000-00003. |
| [3] |
JI Y, YANG K, PENG S, et al. Kaposiform haemangioendothelioma: Clinical features, complications and risk factors for Kasabach-Merritt phenomenon[J]. Br J Dermatol, 2018, 179(2): 457-463. DOI: 10.1111/bjd.16601. |
| [4] |
READ WL, WILLIAMS F. Metastatic angiosarcoma with Kasabach-Merritt syndrome responsive to gemcitabine and vinorelbine after failure of liposomal doxorubicin and paclitaxel: A case report[J]. Case Rep Oncol, 2016, 9(1): 177-181. DOI: 10.1159/000444747. |
| [5] |
SINGH G, MILLS C, ASADI K, et al. Hepatic angiosarcoma as a cause of acute liver failure[J]. BMJ Case Rep, 2018, 2018: bcr2018225896. DOI: 10.1136/bcr-2018-225896. |
| [6] |
SÁNCHEZ RODRÍGUEZ E, PINILLA PAGNON I, RÍOS LEON R, et al. Hepatic angiosarcoma in a patient with liver cirrhosis[J]. Gastroenterol Hepatol, 2019, 42(5): 304-305. DOI: 10.1016/j.gastrohep.2018.10.011. |
| [7] |
CHAUDHARY P, BHADANA U, SINGH RA, et al. Primary hepatic angiosarcoma[J]. Eur J Surg Oncol, 2015, 41(9): 1137-1143. DOI: 10.1016/j.ejso.2015.04.022. |
| [8] |
ZHU XX, LI ZW, ZHENG Y. A case of primary hepatic angiosarcoma with splenic metastasis and rupturet[J]. J Clin Hepatol, 2019, 35(3): 608-610. DOI: 10.3969/j.issn.1001-5256.2019.03.032. |
| [9] |
DROLET BA, TRENOR CC 3rd, BRANDǍO LR, et al. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma[J]. J Pediatr, 2013, 163(1): 285-291. DOI: 10.1016/j.jpeds.2013.03.080. |
| [10] |
Society of Internal Medicaine, Chinese Medical Associatiol; WANG JX, ZHANG FC, et al. Expert consensus for diagnosis and treatment of thrombocytopenia in China[J]. Clin J Inern Med, 2020, 59(7): 498-510. DOI: 10.3760/cma.j.cn112138-20200424-00419. |
| [11] |
LI J, CHEN RY, ZHANG JX, et al. The CT manifestations and differential diagnosis of hepatic angiosarcoma[J]. J Clin Radiol, 2018, 37(6): 968-971. DOI: 10.13437/j.cnki.jcr.2018.06.021. |
| [12] |
SHIMADA K, NAKAMOTO Y, ISODA H, et al. FDG PET for giant cavernous hemangioma: Important clue to differentiate from a malignant vascular tumor in the liver[J]. Clin Nucl Med, 2010, 35(12): 924-926. DOI: 10.1097/RLU.0b013e3181f9de11. |
| [13] |
YOSHIDA Y, YOSHIZUMI T, WANG H, et al. Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: Case report[J]. Surg Case Rep, 2017, 3(1): 21. DOI: 10.1186/s40792-017-0296-0. |
| [14] |
KATZ D, PALMERINI E, POLLACK SM. More than 50 subtypes of soft tissue sarcoma: Paving the path for histology-driven treatments[J]. Am Soc Clin Oncol Educ Book, 2018, 38: 925-938. DOI: 10.1200/EDBK_205423. |
| [15] |
ZHENG YW, ZHANG XW, ZHANG JL, et al. Primary hepatic angiosarcoma and potential treatment options[J]. J Gastroenterol Hepatol, 2014, 29(5): 906-911. DOI: 10.1111/jgh.12506. |
| [16] |
PARK YS, KIM JH, KIM KW, et al. Primary hepatic angiosarcoma: Imaging findings and palliative treatment with transcatheter arterial chemoembolization or embolization[J]. Clin Radiol, 2009, 64(8): 779-785. DOI: 10.1016/j.crad.2009.02.019. |
| [17] |
CASTALDO ET, PINSON CW. Liver transplantation for non-hepatocellular carcinoma malignancy[J]. HPB (Oxford), 2007, 9(2): 98-103. DOI: 10.1080/13651820601156090. |
| [18] |
LI KL, YAO W, QIN ZP, et al. Chinese expert consensus on diagnosis and treatment of Kasabach-Merritt phenomenon[J]. CJOMS, 2019, 17(2): 97-105. DOI:10.19438/j.cjoms.201 9.02.001.
|
| [19] |
QIAO Y, YANG J, LIU L, et al. Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: A case report[J]. BMC Cancer, 2018, 18(1): 212. DOI: 10.1186/s12885-018-3996-3. |
| [20] |
PAOLUZZI L, CACAVIO A, GHESANI M, et al. Response to anti-PD1 therapy with nivolumab in metastatic sarcomas[J]. Clin Sarcoma Res, 2016, 6: 24. DOI: 10.1186/s13569-016-0064-0. |
DownLoad:
